Artificial intelligence in pharmaceutical regulatory affairs-Reference-Cited by-同舟云学术

Artificial intelligence in pharmaceutical regulatory affairs

Published:2023-09 Issue:9 Volume:28 Page:103700
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Patil Ruchika S.,Kulkarni Samruddhi B.,Gaikwad Vinod L.^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference37 articles.

1. Artificial intelligence in drug discovery and development;Paul;Drug Discov Today,2021

2. Artificial intelligence: implications for the future of work;Howard;Am J Ind Med,2019

3. Qualityze. Everything you need to manage organization-wide compliance. Accessed 5 July 2022. https://www.qualityze.com/

4. Nexocode. AI in Pharma. What does artificial intelligence bring to the pharmaceutical industry? Accessed 2 April 2023. https://nexocode.com/blog/posts/ai-in-pharma/. Published March 2, 2021.

5. Customer centricity in medical affairs needs human-centric artificial intelligence;Bedenkov;Pharmaceut Med,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AI in Predictive Toxicology;Advances in Medical Technologies and Clinical Practice;2024-09-27

2. Impact of AI on Manufacturing and Quality Assurance in Medical Device and Pharmaceuticals Industry;International Journal of Innovative Technology and Exploring Engineering;2024-08-30

3. Advancing Pharmacy Practice: The Role of Intelligence-Driven Pharmacy Practice and the Emergence of Pharmacointelligence;Integrated Pharmacy Research and Practice;2024-08

4. Advances in artificial intelligence for drug delivery and development: A comprehensive review;Computers in Biology and Medicine;2024-08

5. Building Quality into the Regulatory Review Practice for Competent Authorities;Pharmaceutical Science;2024-07-10